FFCP PHASE1:Mm9::chr8:86264045..86264057,-: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{FFCP
|id=chr8:86264045..86264057,-
|short_description=p@chr8:86264045..86264057,-
|description=CAGE_peak_at_chr8:86264045..86264057,-
|association_with_transcript=NA
|E...") |
No edit summary |
||
(7 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
| | |DHSsupport=NA | ||
| | |DPIdataset=NA | ||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |||
|cluster_id=chr8:86264045..86264057,- | |||
|description=CAGE_peak_at_chr8:86264045..86264057,- | |||
|id=chr8:86264045..86264057,- | |||
|ontology_enrichment_celltype=CL:0000988!3.25e-19!32;CL:0002032!3.25e-19!32;CL:0000037!3.25e-19!32;CL:0000566!3.25e-19!32;CL:0000837!3.25e-19!32;CL:0002031!2.49e-16!25;CL:0000553!3.02e-13!6;CL:0000556!3.02e-13!6;CL:0000838!1.80e-12!12;CL:0002320!2.01e-12!46;CL:0000134!2.01e-12!46;CL:0000542!1.94e-11!13;CL:0000051!1.94e-11!13;CL:0000084!3.81e-10!11;CL:0000827!3.81e-10!11;CL:0000219!3.98e-10!54;CL:0000049!3.10e-09!19;CL:0000034!4.55e-09!97;CL:0000791!4.92e-09!9;CL:0000789!4.92e-09!9;CL:0002420!4.92e-09!9;CL:0002419!4.92e-09!9;CL:0000790!4.92e-09!9;CL:0000050!9.83e-09!9;CL:0000738!1.61e-08!17;CL:0002087!1.61e-08!17;CL:0000063!9.84e-08!66;CL:0000723!1.04e-07!91;CL:0000048!1.04e-07!91;CL:0000414!4.35e-07!11;CL:0000624!7.53e-07!8 | |||
|ontology_enrichment_celltype_v019_2=CL:0002031,2.86e-11,25;CL:0000838,4.87e-11,12;CL:0000542,3.26e-10,13;CL:0000051,3.26e-10,13;CL:0000624,8.19e-10,8;CL:0000815,1.44e-09,1;CL:0000792,1.44e-09,1;CL:0000945,6.33e-09,1;CL:0000236,6.33e-09,1;CL:0000826,6.33e-09,1;CL:0000791,8.73e-09,9;CL:0000789,8.73e-09,9;CL:0002420,8.73e-09,9;CL:0002419,8.73e-09,9;CL:0000790,8.73e-09,9;CL:0000988,9.19e-09,32;CL:0002032,9.19e-09,32;CL:0000037,9.19e-09,32;CL:0000837,9.19e-09,32;CL:0000355,1.25e-08,9;CL:0000738,7.13e-08,17;CL:0002087,7.13e-08,17;CL:0000084,2.77e-07,11;CL:0000827,2.77e-07,11 | |||
|ontology_enrichment_disease=DOID:0060100!7.17e-11!3;DOID:4045!7.17e-11!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.36e-24,3;DOID:4045,1.36e-24,3;DOID:0050686,1.20e-12,6 | |||
|ontology_enrichment_uberon=UBERON:0002384!2.01e-12!46;UBERON:0002390!1.11e-07!45;UBERON:0003061!1.11e-07!45;UBERON:0002193!4.65e-07!48;UBERON:0002204!9.83e-07!32 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.25e-08,9;UBERON:0002036,1.25e-08,9;UBERON:0002385,1.25e-08,9;UBERON:0000486,1.25e-08,9;UBERON:0007503,1.25e-08,9;UBERON:0001015,1.25e-08,9;UBERON:0002329,1.25e-08,9;UBERON:0003082,1.25e-08,9;UBERON:0003059,1.25e-08,9;UBERON:0007282,1.25e-08,9;UBERON:0004290,1.25e-08,9;UBERON:0009618,1.25e-08,9;UBERON:0000383,8.07e-08,10;UBERON:0007524,3.71e-07,11;UBERON:0003077,3.71e-07,11;UBERON:0007285,3.71e-07,11 | |||
|phase1_expression=0,0,0,0,0,0,0,5.68142623142936,0,0.234064526321993,0,0,6.33442700745461,2.71003247498892,0.333109761815663,0.404950534779652,0,1.57731082679119,0.822686601634433,1.27316895539409,0,0.198581902401771,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.09265815368454,3.1253413780952,3.66466620781659,26.4704169613956,3.41522742479223,0.971020706062307,0,0,0,0,0,0,0,0,0,1.17447824240415,0,0.672187598284928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11981512450592,0,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.369506380333209,0,0,0.169745085775188,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.169978429993855,0.279902904647316,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.120195449519969,0,0,0,0.100826185136841,0.194915761479505,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,5.68142623142936,0,0.234064526321993,0,0,6.33442700745461,2.71003247498892,0.333109761815663,0.404950534779652,0,1.57731082679119,0.822686601634433,1.27316895539409,0,0.198581902401771,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.09265815368454,3.1253413780952,3.66466620781659,26.4704169613956,3.41522742479223,0.971020706062307,0,0,0,0,0,0,0,0,0,1.17447824240415,0,0.672187598284928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11981512450592,0,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.369506380333209,0,0,0.169745085775188,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.169978429993855,0.279902904647316,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.120195449519969,0,0,0,0.100826185136841,0.194915761479505,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr8:86264045..86264057,- | |||
}} | }} |
Latest revision as of 05:01, 4 August 2015
Short description: | p@chr8:86264045..86264057, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr8:86264045..86264057, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematopoietic lineage restricted progenitor cell | 2.86e-11 | 25 |
lymphoid lineage restricted progenitor cell | 4.87e-11 | 12 |
lymphocyte | 3.26e-10 | 13 |
common lymphoid progenitor | 3.26e-10 | 13 |
CD4-positive, alpha-beta T cell | 8.19e-10 | 8 |
regulatory T cell | 1.44e-09 | 1 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell | 1.44e-09 | 1 |
lymphocyte of B lineage | 6.33e-09 | 1 |
B cell | 6.33e-09 | 1 |
pro-B cell | 6.33e-09 | 1 |
mature alpha-beta T cell | 8.73e-09 | 9 |
alpha-beta T cell | 8.73e-09 | 9 |
immature T cell | 8.73e-09 | 9 |
mature T cell | 8.73e-09 | 9 |
immature alpha-beta T cell | 8.73e-09 | 9 |
hematopoietic cell | 9.19e-09 | 32 |
hematopoietic oligopotent progenitor cell | 9.19e-09 | 32 |
hematopoietic stem cell | 9.19e-09 | 32 |
hematopoietic multipotent progenitor cell | 9.19e-09 | 32 |
multi-potent skeletal muscle stem cell | 1.25e-08 | 9 |
leukocyte | 7.13e-08 | 17 |
nongranular leukocyte | 7.13e-08 | 17 |
T cell | 2.77e-07 | 11 |
pro-T cell | 2.77e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.25e-08 | 9 |
striated muscle tissue | 1.25e-08 | 9 |
muscle tissue | 1.25e-08 | 9 |
multilaminar epithelium | 1.25e-08 | 9 |
epithelial vesicle | 1.25e-08 | 9 |
musculature | 1.25e-08 | 9 |
somite | 1.25e-08 | 9 |
myotome | 1.25e-08 | 9 |
presomitic mesoderm | 1.25e-08 | 9 |
presumptive segmental plate | 1.25e-08 | 9 |
dermomyotome | 1.25e-08 | 9 |
trunk paraxial mesoderm | 1.25e-08 | 9 |
musculature of body | 8.07e-08 | 10 |
dense mesenchyme tissue | 3.71e-07 | 11 |
paraxial mesoderm | 3.71e-07 | 11 |
presumptive paraxial mesoderm | 3.71e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.36e-24 | 3 |
muscle cancer | 1.36e-24 | 3 |
organ system cancer | 1.20e-12 | 6 |